|
Integra Lifesciences Holdings Corp (NASDAQ: IART) |
|
Integra Lifesciences Holdings Corp
IART's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Integra Lifesciences Holdings growth rates, revenue grew
by 3.74 % in the first quarter of 2025 from the same quarter a year ago.
Ranking at No. 1719
Medical Equipment & Supplies industry recorded
deterioration of revenues by -3.26 %
Integra Lifesciences Holdings net loss increased from $-3 millions, to $-25 millions in first quarter of 2025,
• More on IART's Growth
|
|
Integra Lifesciences Holdings realized a net loss in trailing twelve months.
Integra Lifesciences Holdings realized cash reduction of $ -4.61 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.57.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.08.
• More on IART's Valuation
|
|
|
|
|
Integra Lifesciences Holdings realized net loss in trailing twelve months.
Integra Lifesciences Holdings realized cash outflow of $ -4.61per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.57.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.08.
Integra Lifesciences Holdings Price to Book Ratio is at 0.61 higher than Industry Avg. of -501.31, and higher than S&P 500 Avg. of 0.01
• More on IART's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com